276 related articles for article (PubMed ID: 30998422)
1. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris.
Sayyafan MS; Ramzi M; Salmanpour R
J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face.
Gupta AK; Lynde CW; Kunynetz RA; Amin S; Choi K; Goldstein E
J Cutan Med Surg; 2003; 7(1):31-7. PubMed ID: 12362264
[TBL] [Abstract][Full Text] [Related]
4. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Langner A; Sheehan-Dare R; Layton A
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
[TBL] [Abstract][Full Text] [Related]
5. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
6. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
8. An observer-blind parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne.
Cunliffe WJ; Fernandez C; Bojar R; Kanis R; West F;
J Dermatolog Treat; 2005; 16(4):213-8. PubMed ID: 16302325
[TBL] [Abstract][Full Text] [Related]
9. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
10. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris.
Burke B; Eady EA; Cunliffe WJ
Br J Dermatol; 1983 Feb; 108(2):199-204. PubMed ID: 6218815
[TBL] [Abstract][Full Text] [Related]
11. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
Tunca M; Akar A; Ozmen I; Erbil H
Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of erythromycin-resistant propionibacteria on the skin of acne patients by topical erythromycin with and without zinc.
Bojar RA; Eady EA; Jones CE; Cunliffe WJ; Holland KT
Br J Dermatol; 1994 Mar; 130(3):329-36. PubMed ID: 8148274
[TBL] [Abstract][Full Text] [Related]
13. Skin microbiome and acne vulgaris: Staphylococcus, a new actor in acne.
Dreno B; Martin R; Moyal D; Henley JB; Khammari A; Seité S
Exp Dermatol; 2017 Sep; 26(9):798-803. PubMed ID: 28094874
[TBL] [Abstract][Full Text] [Related]
14. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris.
Chalker DK; Shalita A; Smith JG; Swann RW
J Am Acad Dermatol; 1983 Dec; 9(6):933-6. PubMed ID: 6227643
[TBL] [Abstract][Full Text] [Related]
15. Topical erythromycin with zinc in acne. A double-blind controlled study.
Feucht CL; Allen BS; Chalker DK; Smith JG
J Am Acad Dermatol; 1980 Nov; 3(5):483-91. PubMed ID: 6452464
[TBL] [Abstract][Full Text] [Related]
16. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
[TBL] [Abstract][Full Text] [Related]
17. Topical antibacterial therapy for acne vulgaris.
Dreno B
Drugs; 2004; 64(21):2389-97. PubMed ID: 15481998
[TBL] [Abstract][Full Text] [Related]
18. A 4% erythromycin and zinc combination (Zineryt) versus 2% erythromycin (Eryderm) in acne vulgaris: a randomized, double-blind comparative study.
Habbema L; Koopmans B; Menke HE; Doornweerd S; De Boulle K
Br J Dermatol; 1989 Oct; 121(4):497-502. PubMed ID: 2533878
[TBL] [Abstract][Full Text] [Related]
19. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
Schachner L; Pestana A; Kittles C
J Am Acad Dermatol; 1990 Mar; 22(3):489-95. PubMed ID: 2138180
[TBL] [Abstract][Full Text] [Related]
20. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle.
Mills O; Thornsberry C; Cardin CW; Smiles KA; Leyden JJ
Acta Derm Venereol; 2002; 82(4):260-5. PubMed ID: 12361129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
